CSPHF
Price:
$0.893
Market Cap:
$7.53B
CStone Pharmaceuticals, a biopharmaceutical company, researches, develops, and commercializes immuno-oncology and precision medicines to address the unmet medical needs of cancer patients in China and internationally. It offers Sugemalimab, a monoclonal antibody against programmed death (PD) ligand 1; GAVRETO, an RET inhibitor for the treatment of patients with advanced or metastatic RET-mutant medullary and RET fusion-positive thyroid cancers; and avapritinib, a KIT/PDGFRA inhibitor to treat adults with unresectable or metastatic gastrointestinal stromal tumors harboring a PDGFRA exon 18 mutation. The company's product pipeline includes Nofazinlimab, a PD-1 antibody for the treatment of pat...[Read more]
Industry
Biotechnology
IPO Date
2020-09-14
Stock Exchange
OTC
Ticker
CSPHF
According to CStone Pharmaceuticals’s latest financial reports and current stock price. The company's current ROE is -71.29%. This represents a change of 175.54% compared to the average of -25.87% of the last 4 quarters.
The mean historical ROE of CStone Pharmaceuticals over the last ten years is -116.16%. The current -71.29% ROE has changed -38.63% with respect to the historical average. Over the past ten years (40 quarters), CSPHF's ROE was at its highest in in the June 2024 quarter at 3.36%. The ROE was at its lowest in in the December 2018 quarter at -244.79%.
Average
-116.16%
Median
-80.39%
Minimum
-338.67%
Maximum
-25.07%
Discovering the peaks and valleys of CStone Pharmaceuticals ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 367.42%
Maximum Annual ROE = -25.07%
Minimum Annual Increase = -72.53%
Minimum Annual ROE = -338.67%
| Year | ROE | Change |
|---|---|---|
| 2024 | -25.07% | -68.82% |
| 2023 | -80.39% | -59.99% |
| 2022 | -200.90% | 26.29% |
| 2021 | -159.08% | 285.27% |
| 2020 | -41.29% | -55.61% |
| 2019 | -93.02% | -72.53% |
| 2018 | -338.67% | 367.42% |
| 2017 | -72.46% | 109.83% |
The current ROE of CStone Pharmaceuticals (CSPHF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-102.12%
5-year avg
-101.34%
10-year avg
-116.16%
CStone Pharmaceuticals’s ROE is greater than Kuros Biosciences AG (-9.00%), greater than Mesoblast Limited (-15.13%), greater than Ascletis Pharma Inc. (-13.49%), greater than PeptiDream Inc. (-9.00%), less than Pharma Mar, S.A. (21.28%), greater than Oxford Nanopore Technologies plc (-19.36%), greater than China Traditional Chinese Medicine Holdings Co. Limited (-1.26%), greater than SanBio Company Limited (-256.50%), greater than Ryman Healthcare Limited (-10.21%), less than Neuren Pharmaceuticals Limited (43.38%),
| Company | ROE | Market cap |
|---|---|---|
| -9.00% | $1.49B | |
| -15.13% | $1.73B | |
| -13.49% | $1.52B | |
| -9.00% | $1.41B | |
| 21.28% | $1.48B | |
| -19.36% | $1.71B | |
| -1.26% | $1.38B | |
| -256.50% | $1.18B | |
| -10.21% | $1.39B | |
| 43.38% | $1.55B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CStone Pharmaceuticals using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like CStone Pharmaceuticals or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is CStone Pharmaceuticals's ROE?
How is the ROE calculated for CStone Pharmaceuticals (CSPHF)?
What is the highest ROE for CStone Pharmaceuticals (CSPHF)?
What is the 3-year average ROE for CStone Pharmaceuticals (CSPHF)?
What is the 5-year average ROE for CStone Pharmaceuticals (CSPHF)?
How does the current ROE for CStone Pharmaceuticals (CSPHF) compare to its historical average?